Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Toritse Orubu"'
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e40167 (2012)
CD8(+) T cell responses to vaccinia virus are directed almost exclusively against early gene products. The attenuated strain modified vaccinia virus Ankara (MVA) is under evaluation in clinical trials of new vaccines designed to elicit cellular immun
Externí odkaz:
https://doaj.org/article/637a937165534b80ab7489b613ec72bf
Autor:
Birgitte K. Giersing, Courtney Jarrahian, Toritse Orubu, Collrane Frivold, Darin Zehrung, Nicolas Peyraud
Publikováno v:
Vaccine, 37(32):4427-4434
Microarray patches (MAPs), also referred to as microneedle patches, are a novel methodology that have the potential to overcome barriers to vaccine delivery in low- and middle-income countries (LMICs), and transform the way that vaccines are delivere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b65bad24ee3976ad19eef4a83ad483
https://doi.org/10.1016/j.vaccine.2019.03.035
https://doi.org/10.1016/j.vaccine.2019.03.035
Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter
Autor:
Toritse Orubu, Adrian V. S. Hill, Sarah C. Gilbert, Senthil Chinnakannan, Ahmed M. Salman, Claire M. Tully, Simon J. Draper, Alexandra J. Spencer, Naif Khalaf Alharbi, Teresa Lambe, Susan J. Morris, Yuko Yamaguchi
Modified vaccinia virus Ankara (MVA)-vectored vaccines against malaria, influenza, tuberculosis and recently Ebola virus are in clinical development. Although this vector is safe and immunogenic in humans, efforts remain on-going to enhance immunogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c024795f43f6e1e4d95e5f142bbb1f54
https://doi.org/10.1016/j.vaccine.2015.11.028
https://doi.org/10.1016/j.vaccine.2015.11.028
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e40167 (2012)
PLoS ONE
PLoS ONE
CD8(+) T cell responses to vaccinia virus are directed almost exclusively against early gene products. The attenuated strain modified vaccinia virus Ankara (MVA) is under evaluation in clinical trials of new vaccines designed to elicit cellular immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::446405766def875f9da546fa1bf8cc51
http://europepmc.org/articles/PMC3384612?pdf=render
http://europepmc.org/articles/PMC3384612?pdf=render